Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha
- 574 Downloads
As a member of the GLI-Kruppel family of transcriptional factors, Yin Yang-1 (YY1) functions as an oncogene in various types of cancers. However, the role of YY1 in hepatocellular carcinogenesis remains unknown. In this report, we investigated the relevance of YY1 to hepatocellular carcinoma (HCC) development. We found that YY1 was upregulated in HCC cell lines. Ectopic YY1 expression promoted the growth of non-tumor liver cells that expressed low level of YY1. In contrast, YY1 depletion inhibited the growth of HCC cells which was accompanied with distinct morphological changes. Moreover, the phenotypic changes induced by YY1 depletion were attributed to cellular differentiation rather than cellular senescence. CCAAT/enhancer-binding protein alpha (CEBPA) which was important to regulate differentiation of hepatocytes was found as the direct target downregulated by YY1. Restoration of CEBPA in YY1-expressing HCC cells induced cellular differentiation and growth inhibition while knockdown of CEBPA expression in non-tumor liver cells promoted cell growth. In summary, our study demonstrated that YY1 could promote hepatocellular carcinogenesis and inhibit cellular differentiation through the downregulation of CEBPA expression.
KeywordsOncogene Cancer Carcinogenesis
This work was supported by Program for Innovative Research Team in Zhejiang Province (grant no. 2010R50046), Natural Science Foundation of Zhejiang Province to LF (grant no. Y2110257) and Program for New Century Excellent Talents in University to HJ.
- 8.Tong ZT, Cai MY, Wang XG, Kong LL, Mai SJ, Liu YH, Zhang HB, Liao YJ, Zheng F, Zhu W et al (2011) EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene. doi:10.1038/onc.2011.254
- 9.de Nigris F, Crudele V, Giovane A, Casamassimi A, Giordano A, Garban HJ, Cacciatore F, Pentimalli F, Marquez-Garban DC, Petrillo A et al (2010) CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy. Proc Natl Acad Sci U S A 107:14484–14489. doi:10.1073/pnas.1008256107 PubMedCrossRefGoogle Scholar
- 12.Lee MH, Lahusen T, Wang RH, Xiao C, Xu X, Hwang YS, He WW, Shi Y, Deng CX (2011) Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation. Oncogene. doi:10.1038/onc.2011.217
- 18.Tan EH, Hooi SC, Laban M, Wong E, Ponniah S, Wee A, Wang ND (2005) CCAAT/enhancer binding protein alpha knock-in mice exhibit early liver glycogen storage and reduced susceptibility to hepatocellular carcinoma. Cancer Res 65:10330–10337. doi:10.1158/0008-5472.CAN-04-4486 PubMedCrossRefGoogle Scholar
- 24.Bennett KL, Romigh T, Arab K, Teresi RE, Tada Y, Eng C, Plass C (2009) Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma. Int J Cancer 124:1285–1292. doi:10.1002/ijc.24087 PubMedCrossRefGoogle Scholar
- 27.Teng CF, Wu HC, Tsai HW, Shiah HS, Huang W, Su IJ (2011) Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy. Hepatology 54:1199–1207. doi:10.1002/hep.24529 PubMedCrossRefGoogle Scholar